Clinical Trials Logo

Antiseptic clinical trials

View clinical trials related to Antiseptic.

Filter by:
  • None
  • Page 1

NCT ID: NCT05934253 Recruiting - Anesthesia, Local Clinical Trials

The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine

Start date: July 15, 2023
Phase: Phase 4
Study type: Interventional

To evaluate if Iheezo's (chloroprocaine 3%) gel vehicle acts as a barrier on the ocular surface, potentially blocking the bactericidal action of povidone-iodine.

NCT ID: NCT05276102 Recruiting - Irritation/Irritant Clinical Trials

The Effects of Repeated Exposure to Antiseptics During COVID-19 Pandemic on Skin Parameters

Start date: March 7, 2022
Phase: N/A
Study type: Interventional

The global coronavirus disease pandemic (COVID-19) has led to an increased need to wear protective equipment such as wearing face masks and practicing hygiene measures such as more frequent use of antiseptics. These measures can lead to changes in the skin, the development of new inflammatory skin diseases or exacerbation of existing ones, with health professionals especially under the risk of developing these changes. Changes in the skin of the hands due to the use of antiseptics have been observed in a number of studies, however, part of the study was based solely on subjects' self-assessment or clinical assessment of researchers, and only a small part on objective measurements of skin parameters. Also, the impact of prolonged use of antiseptics and the impact of measures to prevent and protect against irritation such as topical application of emollient preparations have not been investigated. The impact of repeated use of antiseptics in the repeated exposure model on the forearms will be investigated. This model is a modification of the existing model of irritative dermatitis induced by sodium lauryl sulfate where the original irritant was replaced by an antiseptic solution.

NCT ID: NCT04701502 Completed - Covid19 Clinical Trials

Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19

Start date: November 9, 2020
Phase: Phase 2
Study type: Interventional

This is a two-arm, randomized, open label, two-center, controlled study to evaluate the safety and efficacy of Viusid plus Asbrip in patients with mild and moderate symptoms of respiratory illness caused by Coronavirus 2019 infection.